Multicentre, phase II study of eribulin in combination with S-1 in patients with advanced breast cancer.

Tsutomu IwasaJunji TsurutaniSatomi WatanabeRyoji KatoYutaka MizunoYasuyuki KojimaTsutomu TakashimaNobuki MatsunamiTakashi MorimotoJun YamamuraShoichiro OhtaniYuko TanabeTetsuhiro YoshinamiToshimi TakanoYoshifumi KomoikeKazuhiko Nakagawa

Published in: BMC cancer (2019)

Current Controlled Trials UMIN000015049 , date of registration: September 5th 2014.

Keyphrases

phase ii study
open label
locally advanced
phase ii
clinical trial
metastatic breast cancer
study protocol
placebo controlled
double blind
cross sectional
rectal cancer
squamous cell carcinoma
randomized controlled trial
radiation therapy
phase iii